Mckesson Packaging Services FDA Record

Warning letters, Form 483s, inspections, recalls and 510(k) clearances

  • Latest inspection VAI · Dec 15, 2017
  • No warning letters matched by name
Inspections 5 0 OAI
Recalls 17 0 Class I (0%)
Warning letters 0 None on file
510(k) clearances 0 None on file

Mckesson Packaging Services has 17 FDA recalls, 5 inspections, 0 510(k) clearances and 0 compliance actions on record. No FDA warning letter addressed to "Mckesson Packaging Services" is on file.

What these totals cover: FDA records filed under the name "Mckesson Packaging Services".

Latest recall
D-0714-2018 · Class III · Apr 23, 2018
Latest inspection
Dec 15, 2017 · VAI

Summary

Record counts and when each FDA source was last refreshed
RecordsCountLast refreshedSource as ofStatus
Recalls17Nov 15, 2026File dated Nov 10, 2026Current
510(k) clearances0Nov 15, 2026File dated Nov 9, 2026Current
Inspections5Nov 17, 2026Newest record Nov 9, 2026Current
Compliance actions0Nov 2, 2026Newest record Oct 29, 2026Current

FDA record by year

Mckesson Packaging Services's FDA inspections, warning letters and recalls in each of the last 10 calendar years (2017 to 2026, 2026 so far).

Mckesson Packaging Services: FDA inspections per year

2017: 1 inspection (0 OAI), 0 warning letters, 4 recall records (0 Class I) 2018: 0 inspections (0 OAI), 0 warning letters, 5 recall records (0 Class I) 2019: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2020: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2021: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2022: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2023: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2024: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2025: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2026: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I)
YearInspectionsOAIWarning lettersRecall recordsClass I
202600000
202500000
202400000
202300000
202200000
202100000
202000000
201900000
201800050
201710040

Inspections are counted by the date they ended, warning letters by the date FDA issued them and recall records by the recall start date. FDA lists one recall record per recalled product, so one recall event can add several.

Reviewing Mckesson Packaging Services as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.

Check this supplier

Or check Mckesson Packaging Services yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.

Get a free API key

Recent recalls

17 recall records from Mar 29, 2012 to Apr 23, 2018.

NumberClassProductDate
D-0714-2018Class IIIDiltiazem HCl Extended-Release Capsules, USP 120 mg, 100-count bottles, Rx only, Mfg. By: Par…Apr 23, 2018
D-0716-2018Class IIIDiltiazem HCl Extended-Release Capsules, USP 240 mg, 100-count bottles, Rx Only, Mfg. By: Par…Apr 23, 2018
D-0715-2018Class IIIDiltiazem CD (Diltiazem Hydrochloride Extended-Release Capsules, USP) 180 mg, 100-count bottles, Rx…Apr 23, 2018
D-0914-2018Class IIRANITIDINE Tablets, USP 150 mg UD 100 tablets (10x10), RX Only, Manufactured by: Amneal…Feb 26, 2018
D-0338-2018Class IIIMegestrol Acetate Oral Suspension, USP 400 mg/ 10mL (10 mL UD cups in boxes of 20 cups), Rx Only…Jan 29, 2018
D-1128-2017Class IIIPropafenone Hydrochloride tablets, 150 mg, packaged in 10 x 10 unit dose cards (100-count box), Rx…Aug 28, 2017
D-0928-2017Class IIIBuPROPion HCL Tablets, USP, 75 mg, packaged as UD 100 tablets (10x10), Rx Only, Mfg by: Sandoz Inc…May 30, 2017
D-0513-2017Class IIAspirin Chewable Tablets, 81 mg, (NSAID*), packaged in UD 750 Tablets (25 x 30) tablets in blisters…Feb 23, 2017
D-0680-2017Class IIIDonepezil HCl tablets, 10mg, packaged in 10x10 blister packs per carton (100 Unit Dose) container…Jan 4, 2017
D-1527-2016Class IIIXanax (Alprazolam) USP, CIV, 0.5 mg tablets , 10 x 10 blister cards per carton, Rx Only…Sep 15, 2016
D-1550-2016Class IIILansoprazole Delayed-Release Capsules, USP, 30 mg, packaged in 100-count cartons of 10 x 10 unit…Sep 8, 2016
D-0834-2016Class IIISKY Aspirin Chewable Tablets, 81 mg, Unit Dose 750 tablets (25 x 30) box, OTC, Distributed by…Apr 12, 2016
D-1515-2014Class IIAlprazolam Tablets, USP 0.25 mg, UD 100 Tablets (10 x 10), Rx Only, Mfg By: Sandoz, Inc., Princeton…Jul 30, 2014
D-1483-2014Class IIIAspirin DR Enteric Coated Tablets, USP 325 mg, UD 750 tablets (25x30), Dist. By: McKesson Packaging…Jun 19, 2014
D-1167-2014Class IIIVenlafaxine Hydrochloride, Extended Release Capsules, 150 mg, UD-100 Tablets per Box (10 x 10), Rx…Mar 3, 2014
D-002-2013Class IIIbuPROPion Hydrochloride Extended-Release Tablets (XL), 300 mg, UD 100 Tablets (10 x 10) per carton…Mar 29, 2012
D-001-2013Class IIIbuPROPion Hydrochloride Extended-Release Tablets (XL), 150 mg, UD 100 Tablets (10 x 10) per carton…Mar 29, 2012

Recent FDA inspections

5 inspections from Jan 28, 2010 to Dec 15, 2017.

DateSiteProductClassificationFEI
Dec 15, 2017Concord, NCDrugsVoluntary Action Indicated (VAI)3000206187
Apr 22, 2016Concord, NCDrugsVoluntary Action Indicated (VAI)3000206187
May 29, 2014Concord, NCDrugsVoluntary Action Indicated (VAI)3000206187
Dec 12, 2011Concord, NCDrugsNo Action Indicated (NAI)3000206187
Jan 28, 2010Concord, NCDrugsNo Action Indicated (NAI)3000206187
NAI
No objectionable conditions or practices were found during the inspection.
VAI
Objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action.
OAI
Regulatory and/or administrative actions are recommended.

Look up the inspector observations behind these results with the FDA 483 search, or check for formal enforcement with the FDA warning letter search.

FDA-inspected facilities

1 inspected site, newest inspection first.

FacilityLocationInspectionsLatest
FEI 3000206187Concord, NC5Dec 15, 2017

Mckesson Packaging Services and the FDA: common questions

Has Mckesson Packaging Services received an FDA warning letter?

No FDA warning letter addressed to the name "Mckesson Packaging Services" is on file. This answer covers that name only: letters addressed to a related company name or to one of its sites are listed on that name's or site's own page.

Has Mckesson Packaging Services received an FDA Form 483?

FDA has not published a Form 483 for "Mckesson Packaging Services" in its reading room. FDA publishes some Form 483s, not all of them.

When did the FDA last inspect Mckesson Packaging Services?

The most recent FDA inspection on file ended Dec 15, 2017 at Concord, NC and was classified VAI. FDA has 5 inspections of Mckesson Packaging Services on file.

Has Mckesson Packaging Services had an FDA recall?

Yes. Mckesson Packaging Services has 17 FDA recalls on record. The most recent started Apr 23, 2018.

Need more than this page shows? Ask about Mckesson Packaging Services in Claude or ChatGPT and get every site's inspections, Form 483s, warning letters and import alerts, with a link to the FDA source for each record. The API key is free: no card.

Get a free API key

Prefer a PDF? Request a free supplier snapshot.

Is this your company or a supplier you list? Link to this FDA record from your site with a free button.

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.